Table 4.
Comparison of Cassidy Scale for Manic States scores across the three treatment groups
| CSMS | Treatment group | Mean±SD | df | F | P |
|---|---|---|---|---|---|
| Baseline | Lithium | 45.03±7.26 | 2 | 1.814 | 0.171 |
| Carbamazepine | 44.00±8.22 | ||||
| Sodium valproate | 48.47±6.746 | ||||
| First week | Lithium | 24.00±8.97 | 2 | 0.045 | 0.956 |
| Carbamazepine | 25.65±9.24 | ||||
| Sodium valproate | 24.82±12.99 | ||||
| Second week | Lithium | 17.20±7.89 | 2 | 1.347 | 0.267 |
| Carbamazepine | 22.00±12.98 | ||||
| Sodium valproate | 16.94±13.66 | ||||
| Third week | Lithium | 15.97±11.11 | 2 | 0.684 | 0.508 |
| Carbamazepine | 20.35±14.90 | ||||
| Sodium valproate | 16.52±15.44 | ||||
| Fourth week | Lithium | 17.36±12.28 | 2 | 1.941 | 0.152 |
| Carbamazepine | 21.70±15.04 | ||||
| Sodium valproate | 12.82±14.31 | ||||
| Fifth week | Lithium | 13.30±11.45 | 2 | 1.492 | 0.233 |
| Carbamazepine | 18.95±15.36 | ||||
| Sodium valproate | 12.00±14.52 |
df – Degree of freedom; P<0.05; F – ANOVA value; CSMS – Cassidy Scale for Manic States; SD – Standard deviation